Loading…

Lutathera PRRT is being used earlier for some neuroendocrine tumor patients following the NETTER-2 trial, and pharmacists manage much of whether each dose is delivered on time. The radioactive peptide loses activity steadily after production, so late delivery or poor timing can cancel treatment.
This is a medical supply and logistics story about a radiopharmaceutical with no bearing on feed ingredients, grain, oilseed or livestock prices.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.